Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Best Peptides for Mitochondrial Optimization: Mechanism Comparison

MOTS-c Activates AMPK and nuclear gene transcription to increase mitochondrial biogenesis Nucleus (mitochondrial-to-nuclear signaling) Preclinical (Phase I trials planned for 2026–2027) Best for increasing mitochondrial density and metabolic flexibility Humani

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • MOTS-c
  • Activates AMPK and nuclear gene transcription to increase mitochondrial biogenesis
  • Nucleus (mitochondrial-to-nuclear signaling)
  • Preclinical (Phase I trials planned for 2026–2027)
  • Best for increasing mitochondrial density and metabolic flexibility
  • Humanin
  • Inhibits Bax-mediated apoptosis, preventing mitochondrial membrane permeabilization
  • Mitochondrial outer membrane
  • Early Phase II (metabolic syndrome trials completed)
  • Best for protecting existing mitochondria during oxidative stress
  • SS-31 (Elamipretide)
  • Binds cardiolipin to stabilize inner membrane and prevent cristae fragmentation
  • Inner mitochondrial membrane
  • Phase III completed (FDA review ongoing)
  • Best for restoring function in damaged mitochondria
  • FOXO4-DRI
  • Disrupts FOXO4-p53 interaction to clear senescent cells and reduce inflammatory ATP drain
  • Cellular senescence pathways (indirect mitochondrial effect)
  • Preclinical (senolytic trials in progress)
  • Best for eliminating senescent cell burden in aged tissues